ADA Scientific Sessions 2026 Abstract
Assessing Type 2 Diabetes and GLP-1 Agonist Response Trajectories with a Proteogenomic Atlas of Disease Progression
Computational studyAI & data
The paper
Boston
ADA Scientific Sessions 2026 Abstract, 5 Jun 2026
Presented at ADA Scientific Sessions 2026, poster 1717-P

